No 01 2018 – Coming soon

The Patent Trial and Appeal Board (PTAB) of the United States Patent and Trademark Office (USPTO) has issued a favorable Decision on Appeal in U.S. patent application No. 18/065,702, Appeal No. 2026-000924, relating to an immediate-release solid oral dosage formulation of resomelagon (AP1189 acetate).

Diamyd Medical has announced that Mathias Skalmstad will take up the position of Chief Financial Officer at Diamyd Medical.

The U.S. Food and Drug Administration (FDA) has approved mFLUSIVA (mRNA-1010), a new vaccine against seasonal influenza, for use in all adults 50 years and older.

“Sandra has been an invaluable member of the Oxcia team, combining scientific excellence with a deep understanding of inflammation as well as our development programs,” says Ulrika Bergman Warpman, CEO. “We are delighted to see her take on this leadership role as we finalize the pre-clinical program for OXC-201 and progress our earlier projects including […]

"SciBase is now entering a new phase where the strategy and foundation is in place, and I feel this is the right time to hand over responsibility to a new CEO," says Pia Renaudin.

Nykode Therapeutics has presented comprehensive preclinical and clinical data on VB10.NEO, its individualized neoantigen therapy (INT), at the Neoantigen Summit in Amsterdam, reinforcing the program as a differentiated platform ready for strategic partnership.

EQL has recruited Oskar Karmlid as its new Chief Supply Chain Officer (CSCO).